SILVER SPRING, Maryland — The US FDA is following in the footsteps of the European Medicines Agency (EMA) in warning that the anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim) should not be ...
LONDON — The European Medicines Agency (EMA) has recommended against approval of mipomersen (Genzyme) for the treatment of familial hypercholesterolemia (FH) because of safety reasons, including ...
ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide ...
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it is conducting a voluntary recall of all production lots for the Duet TRS TM Universal Straight and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results